Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 for Food Sensitivities Research: Protocol Comparison

BPC-157 (Injectable) Tight junction repair via FAK/VEGF pathways + TNF-α/IL-6 suppression 250–500 µg SQ daily (human-equivalent from rodent data) Intestinal permeability (lactulose/mannitol), serum zonulin, cytokine panels, symptom scores 7–14 days for barrier

This comparison does not assign a generated winner or score.

  • BPC-157 (Injectable)
  • Tight junction repair via FAK/VEGF pathways + TNF-α/IL-6 suppression
  • 250–500 µg SQ daily (human-equivalent from rodent data)
  • Intestinal permeability (lactulose/mannitol), serum zonulin, cytokine panels, symptom scores
  • 7–14 days for barrier markers; 21–28 days for symptom reduction
  • Most mechanistically targeted for structural repair; limited human clinical data; requires precise peptide purity
  • L-Glutamine (5–15g daily)
  • Enterocyte fuel source; supports tight junction protein synthesis
  • 5–15g oral powder daily
  • Symptom questionnaires, subjective tolerance improvements
  • 4–8 weeks
  • Well-tolerated, affordable; effect size modest; doesn't address inflammatory cytokines
  • Elimination Diet (IgG-guided)
  • Antigen avoidance to reduce immune activation
  • Remove reactive foods 6–12 weeks, structured reintroduction
  • Symptom resolution, IgG antibody titers (unreliable marker)
  • 6–12 weeks symptom improvement; indefinite for tolerance
  • Symptom control effective; doesn't repair underlying permeability; reintroduction often fails
  • Probiotic Therapy (Multi-strain)
  • Microbial modulation; possible zonulin downregulation
  • 25–100 billion CFU daily
  • Stool microbiome analysis, symptom scores
  • 8–12 weeks
  • Indirect mechanism; strain-dependent; synergistic with barrier repair but insufficient alone
  • Low-FODMAP Diet
  • Reduces osmotic load and bacterial fermentation byproducts
  • Strict 4–6 weeks, gradual reintroduction
  • Symptom scores (bloating, pain, transit time)
  • 2–4 weeks symptom improvement
  • Addresses fermentation triggers, not immune reactivity; restrictive; doesn't restore tolerance
  • Quercetin + Vitamin C
  • Mast cell stabilisation; histamine metabolism support
  • 500mg quercetin + 1000mg vitamin C twice daily
  • Histamine symptom scores, DAO enzyme activity
  • 4–6 weeks
  • Useful for histamine intolerance subset; doesn't address tight junction defects
More references

Related material